Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Sep 05, 2024

SELL
$63.71 - $70.74 $222,985 - $247,589
-3,500 Reduced 57.41%
2,596 $166 Million
Q1 2023

Sep 05, 2024

BUY
$65.71 - $74.53 $400,568 - $454,334
6,096 New
6,096 $407 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Granite Fo LLC Portfolio

Follow Granite Fo LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Fo LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Fo LLC with notifications on news.